Urgent Panendoscopy in Patients Presenting With Hematochezia
Diagnostic Yield of Urgent Panendoscopy VS. Conventional Endoscopic Evaluation in Patients Presenting With Hematochezia : Randomized Controlled Trial
1 other identifier
interventional
188
1 country
1
Brief Summary
Gastrointestinal bleeding is a significant emergency condition requiring prompt diagnosis. Current evidence presents a clinical paradox: urgent colonoscopy (within 24 hours) shows no clear benefit in several studies, while urgent video capsule endoscopy (VCE) demonstrates improved detection rates for small bowel bleeding. This study aims to evaluate a novel approach combining urgent colonoscopy followed by same-day VCE for patients with normal colonoscopy findings. This strategy has not been previously assessed and may improve bleeding source detection while reducing patient preparation burden compared to standard sequential testing. Results will be compared against conventional approaches to determine optimal diagnostic timing for patients presenting with hematochezia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2024
CompletedFirst Submitted
Initial submission to the registry
May 1, 2025
CompletedFirst Posted
Study publicly available on registry
May 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
ExpectedMay 30, 2025
May 1, 2025
Same day
May 1, 2025
May 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic yield of urgent endoscopy compared to standard endoscopy
The bleeding source detection rate between the urgent endoscopy strategy (colonoscopy + EGD + VCE within 24 hour of presentation) to the standard endoscopy strategy (colonoscopy + EGD + VCE within 72 hour of presentation) will be compared.
72 hour
Secondary Outcomes (1)
Rebleeding rate
30 days
Study Arms (2)
Urgent colonoscopy with urgent VCE group
EXPERIMENTALIntervention Arm : Urgent colonoscopy with urgent VCE group : Patients will undergo colonoscopy within 24 hours of diagnosed lower gastrointestinal bleeding. If no bleeding source is identified on colonoscopy or presumed diverticular bleeding cases, esophagogastroduodenoscopy (EGD) followed by same-session video capsule endoscopy (VCE) will be performed immediately
Standard colonoscopy with standard VCE group
EXPERIMENTALControl Arm : Standard colonoscopy with standard VCE group : Patients will undergo colonoscopy within 24-48 hours after diagnosed lower gastrointestinal bleeding. If no bleeding source is identified on colonoscopy or presumed diverticular bleeding cases, esophagogastroduodenoscopy (EGD) will be performed immediately. If EGD shows no bleeding source, video capsule endoscopy (VCE) will be performed within 24 hours of the preceding endoscopies
Interventions
Patients will undergo colonoscopy within 24 hours of diagnosed lower gastrointestinal bleeding. If no bleeding source is identified on colonoscopy or presumed diverticular bleeding cases, esophagogastroduodenoscopy (EGD) followed by same-session video capsule endoscopy (VCE) will be performed immediately
Patients will undergo colonoscopy within 24-48 hours after diagnosed lower gastrointestinal bleeding. If no bleeding source is identified on colonoscopy or presumed diverticular bleeding cases, esophagogastroduodenoscopy (EGD) will be performed immediately. If EGD shows no bleeding source, video capsule endoscopy (VCE) will be performed within 24 hours of the preceding endoscopies
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Admission for maroon stool and/or red blood per rectum with or without hemodynamic instability
- Hemodynamic stabilization after initial fluid resuscitation
- Correction of any coagulopathy prior to endoscopy
- Provision of informed consent
You may not qualify if:
- Hematemesis or nasogastric lavage showing coffee ground material/blood
- Persistent hemodynamic instability prior to colonoscopy
- Hospitalization in the preceding 14 days
- Contraindications to endoscopy e.g. severe asthma, cardiac disease
- Uncorrected coagulopathy
- Contraindications to bowel preparation with polyethylene glycol
- Pregnancy
- Inflammatory bowel disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gastroenterology division, Faculty of Medicine, Siriraj Hospital, Mahidol University Bangkok, , Thailand
Bangkok, Bangkok, 10700, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 1, 2025
First Posted
May 22, 2025
Study Start
April 9, 2024
Primary Completion
April 9, 2024
Study Completion (Estimated)
January 1, 2028
Last Updated
May 30, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Other researchers can contact us anytime
- Access Criteria
- The investigators will provide our protocol and/or data upon request.
The investigators are willing to provide our data to researchers who require it. For example, those who want to do systematic review and meta-analysis